An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Over 200 years ago, René Laennec published the first description of emphysema, an important pathobiological element of what is today known as chronic obstructive pulmonary disease (COPD) (1). He stated that the disease was characterized by persistent dyspnea punctuated by acute episodes of worsening, frequently associated with newly developed and/or worsening cough and sputum (labeled as “acute catarrh”) that could lead to “suffocation.” These episodes have subsequently been termed “exacerbations of COPD” (ECOPDs) (2, 3). Over 150 years later, Anthonisen and colleagues (4) provided a definition, similar to Laennec’s, that has remained relatively unchanged over the last 35 years and forms the basis of the European Respiratory Society/American Thoracic Society definition: “In a patient with underlying COPD, exacerbations are episodes of increasing respiratory symptoms, particularly dyspnea, cough and sputum production, and increased sputum purulence” (5). A slightly modified definition has been used primarily in the research field: “A sustained worsening of the patient’s condition from the stable state and beyond normal day-to-day variations, necessitating a change in regular medication in a patient with underlying COPD” (6). This definition is similar to that in the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy document, which reads, “An acute worsening of respiratory symptoms that results in additional therapy” (7). GOLD then classifies ECOPD severity as mild when only symptoms are reported and the patient is treated with inhaled short-acting bronchodilators; moderate when the patient receives antibiotics, systemic corticosteroids, or both; and severe when the patient visits an emergency room or is hospitalized because of the event (6, 7). Without denying the therapeutic progress made in the prevention of ECOPDs (5–8), treatment of the episodes per se has remained relatively unchanged (5, 7, 9). The current definition of ECOPD has several shortcomings that adversely affect clinical and healthcare decisions (see Table E1 in the online supplement). First, it relies exclusively on a patient’s subjective perception of increased respiratory symptoms, which varies from patient to patient (10) and can be mimicked and/or aggravated by other conditions such as pneumonia, cardiac events, or pulmonary embolism (6, 7, 11, 12). Second, it does not relate the symptoms to measurable pathophysiological variables that could characterize the event itself. Third, it lacks a framework for timing of the event’s evolution, an element that can help differentiate ECOPDs from other processes with similar symptoms. Finally, severity is established post hoc by the healthcare resource used to treat the event (13, 14), with this subjectivity introducing variability due to differences between practitioners and healthcare systems. A novel approach is therefore needed because precise, practical, and objective point-of-care definitions and severity assessments for acute medical events are needed by clinicians and researchers if they are to effectively diagnose them at the point of contact, assess the prognosis, and implement precision treatment (15). All of these shortcomings could be overcome by integrating knowledge gathered from observational and interventional studies, as well as with the help of currently available technology capable of measuring in real time the clinical and laboratory variables that can serve as surrogate markers of event severity. This perspective proposes an updated definition and severity classification of ECOPDs based on the principles outlined by Scadding (16) for the taxonomy of diseases, integrating symptoms, function, and surrogate markers of the process underlying ECOPDs. It intends to be objective, practical, and useful to clinicians and researchers alike. In its development, the authors acknowledge that episodes of the worsening of respiratory symptoms similar to ECOPDs may occur in patients with chronic diseases other than COPD, and these potential causes should be considered in the differential diagnosis of the event (7, 17). The process itself was initiated and coordinated by B.R.C. and L.M.F., aided by a medical writer (D.Y.), who identified experts with international recognition who have conducted research and published on the definition, diagnosis, pathobiology, and/or treatment of ECOPDs as well as similar events in closely related fields. A modified Delphi method (18, 19) was considered the most appropriate scientific tool to achieve the desired goals because 1) it is a valid method to obtain consensus based on informed opinions; 2) it provides a structured mechanism to maintain a fluid communication process, allowing individuals to deal with a complex problem; 3) the issue in question does not lend itself to precise analytical techniques but can benefit from subjective judgments on a collective basis; and 4) the method is based on anonymous responses to the selected items
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diamond, I. R., Grant, R. C., Feldman, B. M., Pencharz, P. B., Ling, S. C., Moore, A. M., & Wales, P. W. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.12.002 · Cited by 3,740
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
ANTHONISEN, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,492
Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure
Rochwerg, B., Brochard, L., Elliott, M. W., Hess, D., Hill, N. S., Nava, S., Navalesi, P., Antonelli, M., Brozek, J., Conti, G., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02426-2016 · Cited by 1,668
Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., BHOWMIK, A., JEFFRIES, D. J., & WEDZICHA, J. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9908022 · Cited by 1,179
Self-citationBafadhel, M., McKenna, S., Terry, S., Mistry, V., Reid, C., Haldar, P., McCormick, M., Haldar, K., Kebadze, T., Duvoix, A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0597oc · Cited by 1,094
Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations
Papi, A., Bellettato, C. M., Braccioni, F., Romagnoli, M., Casolari, P., Caramori, G., Fabbri, L. M., & Johnston, S. L. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-859oc · Cited by 1,072 · cited 1×
“Serum CRP levels increase in both viral and bacterial ECOPD (25, 26), although they are usually higher in the latter (22, 26) which is why values may be used at point-of-care to guide antibiotic therapy (26, 62).”
BackgroundSelf-citationNew Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary Disease
Sethi, S., Evans, N., Grant, B. J. B., & Murphy, T. F. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012561 · Cited by 1,047
Self-citationToward a Consensus Definition for COPD Exacerbations
Rodriguez-Roisin, R. (2000) · Chest · doi:10.1378/chest.117.5_suppl_2.398s · Cited by 969
Self-citationEffect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary Disease
Niewoehner, D. E., Erbland, M. L., Deupree, R. H., Collins, D., Gross, N. J., Light, R. W., Anderson, P., & Morgan, N. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402502 · Cited by 875
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
Wedzicha, J. A., Miravitlles, M., Hurst, J. R., Calverley, P. M. A., Albert, R. K., Anzueto, A., Criner, G. J., Papi, A., Rabe, K. F., Rigau, D., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00791-2016 · Cited by 683
Self-citationBTS guideline for oxygen use in adults in healthcare and emergency settings
O'Driscoll, B. R., Howard, L. S., Earis, J., & Mak, V (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209729 · Cited by 679
Heart Failure and Chronic Obstructive Pulmonary Disease: Diagnostic Pitfalls and Epidemiology
Hawkins, N. M., Petrie, M. C., Jhund, P. S., Chalmers, G. W., Dunn, F. G., & McMurray, J. J. V. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn013 · Cited by 570
C-reactive Protein As a Predictor of Prognosis in Chronic Obstructive Pulmonary Disease
Dahl, M., Vestbo, J., Lange, P., Bojesen, S. E., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-713oc · Cited by 543
Relationship of Sputum Color to Nature and Outpatient Management of Acute Exacerbations of COPD
Stockley, R. A., O’Brien, C., Pye, A., & Hill, S. L. (2000) · Chest · doi:10.1378/chest.117.6.1638 · Cited by 535
Increased Risk of Myocardial Infarction and Stroke Following Exacerbation of COPD
Donaldson, G. C., Hurst, J. R., Smith, C. J., Hubbard, R. B., & Wedzicha, J. A. (2010) · Chest · doi:10.1378/chest.09-2029 · Cited by 514
Self-citationExacerbations of chronic obstructive pulmonary disease
Celli, B. R., & Barnes, P. J. (2007) · European Respiratory Journal · doi:10.1183/09031936.00109906 · Cited by 462
Self-citationUpdate on Clinical Aspects of Chronic Obstructive Pulmonary Disease
Celli, B. R., & Wedzicha, J. A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1900500 · Cited by 461
Self-citationUse of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease
Hurst, J. R., Donaldson, G. C., Perera, W. R., Wilkinson, T. M. A., Bilello, J. A., Hagan, G. W., Vessey, R. S., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-506oc · Cited by 454
Self-citationMallia, P., Message, S. D., Gielen, V., Contoli, M., Gray, K., Kebadze, T., Aniscenko, J., Laza-Stanca, V., Edwards, M. R., Slater, L., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0833oc · Cited by 415
Self-citationInflammatory changes, recovery and recurrence at COPD exacerbation
Perera, W. R., Hurst, J. R., Wilkinson, T. M. A., Sapsford, R. J., Müllerova, H., Donaldson, G. C., & Wedzicha, J. A. (2007) · European Respiratory Journal · doi:10.1183/09031936.00092506 · Cited by 372
Self-citationKunisaki, K. M., Dransfield, M. T., Anderson, J. A., Brook, R. D., Calverley, P. M. A., Celli, B. R., Crim, C., Hartley, B. F., Martinez, F. J., Newby, D. E., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201711-2239oc · Cited by 354
Self-citationMajor air pollutants and risk of COPD exacerbations: a systematic review and meta-analysis
Li, J., Sun, S., Tang, R., Qiu, H., Huang, Q., Mason, T., & Tian, L. (2016) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s122282 · Cited by 283
C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations
Butler, C. C., Gillespie, D., White, P., Bates, J., Lowe, R., Thomas-Jones, E., Wootton, M., Hood, K., Phillips, R., Melbye, H., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1803185 · Cited by 277
Stolz, D., Christ-Crain, M., Morgenthaler, N. G., Leuppi, J., Miedinger, D., Bingisser, R., Müller, C., Struck, J., Müller, B., & Tamm, M. (2007) · Chest · doi:10.1378/chest.06-2336 · Cited by 270
Serum Amyloid A Is a Biomarker of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Bozinovski, S., Hutchinson, A., Thompson, M., MacGregor, L., Black, J., Giannakis, E., Karlsson, A.-S., Silvestrini, R., Smallwood, D., Vlahos, R., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-678oc · Cited by 260
Validity of the numeric rating scale as a measure of dyspnea
Gift, A., & Narsavage, G. (1998) · American Journal of Critical Care · doi:10.4037/ajcc1998.7.3.200 · Cited by 256
Impact of COPD Exacerbations on Patient-Centered Outcomes
Cote, C. G., Dordelly, L. J., & Celli, B. R. (2007) · Chest · doi:10.1378/chest.06-1610 · Cited by 250
Self-citationCOPD exacerbations {middle dot} 3: Pathophysiology
O'Donnell, D. E. (2006) · Thorax · doi:10.1136/thx.2005.041830 · Cited by 207
Self-citationBarbera, J., Roca, J., Ferrer, A., Felez, M., Diaz, O., Roger, N., & Rodriguez-Roisin, R. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10061285 · Cited by 188
Self-citationTime course and pattern of COPD exacerbation onset
Aaron, S. D., Donaldson, G. C., Whitmore, G. A., Hurst, J. R., Ramsay, T., & Wedzicha, J. A. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200768 · Cited by 179
Self-citationPhysiological changes during symptom recovery from moderate exacerbations of COPD
Parker, C. M., Voduc, N., Aaron, S. D., Webb, K. A., & O'Donnell, D. E. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00136304 · Cited by 176
Self-citationDIAZ, O., IGLESIA, R., FERRER, M., ZAVALA, E., SANTOS, C., WAGNER, P. D., ROCA, J., & RODRIGUEZ-ROISIN, R. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.6.9701027 · Cited by 175
Self-citationBlood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD
Bafadhel, M., Greening, N. J., Harvey-Dunstan, T. C., Williams, J. E. A., Morgan, M. D., Brightling, C. E., Hussain, S. F., Pavord, I. D., Singh, S. J., & Steiner, M. C. (2016) · CHEST · doi:10.1016/j.chest.2016.01.026 · Cited by 164
Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease
Dev, D., Wallace, E., Sankaran, R., Cunniffe, J., Govan, J. R. W., Wathen, C. G., & Emmanuel, F. X. S. (1998) · Respiratory Medicine · doi:10.1016/s0954-6111(98)90515-7 · Cited by 162
Pinto-Plata, V., Livnat, G., Girish, M., Cabral, H., Masdin, P., Linacre, P., Dew, R., Kenney, L., & Celli, B. (2007) · Chest · doi:10.1378/chest.06-0668 · Cited by 150
Self-citationResting heart rate is a predictor of mortality in COPD
Jensen, M. T., Marott, J. L., Lange, P., Vestbo, J., Schnohr, P., Nielsen, O. W., Jensen, J. S., & Jensen, G. B. (2013) · European Respiratory Journal · doi:10.1183/09031936.00072212 · Cited by 150
Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD
Aleva, F. E., Voets, L. W. L. M., Simons, S. O., de Mast, Q., van der Ven, A. J. A. M., & Heijdra, Y. F. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.07.034 · Cited by 145
Couturaud, F., Bertoletti, L., Pastré, J., Roy, P., Mao, R. L., Gagnadoux, F., Paleiron, N., Schmidt, J., Sanchez, O., Magalhaes, É. D., et al. (2021) · JAMA · doi:10.1001/jama.2020.23567 · Cited by 122
A Systematic Review of Diagnostic Biomarkers of COPD Exacerbation
Chen, Y. R., Leung, J., & Sin, D. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158843 · Cited by 121
C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis
Leuzzi, G., Galeone, C., Taverna, F., Suatoni, P., Morelli, D., & Pastorino, U. (2017) · European Respiratory Review · doi:10.1183/16000617.0070-2016 · Cited by 120
Borel, J., Pelletier, J., Taleux, N., Briault, A., Arnol, N., Pison, C. M., Tamisier, R., Timsit, J., & Pépin, J. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206569 · Cited by 117
Grime, M. M., & Wright, G. (2016) · Wiley StatsRef: Statistics Reference Online · doi:10.1002/9781118445112.stat07879 · Cited by 112
Miravitlles, M., Moragas, A., Hernandez, S. F., Bayona, C., & Llor, C. (2013) · CHEST Journal · doi:10.1378/chest.13-0518 · Cited by 104
Hurst, J. R., Donaldson, G. C., Quint, J. K., Goldring, J. J., Patel, A. R., & Wedzicha, J. A. (2010) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-10-52 · Cited by 88
Self-citationMultimorbidity in Patients with Chronic Obstructive Pulmonary Disease
Divo, M. J., & Celli, B. R. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.06.002 · Cited by 81
Self-citationRajeh, A. M. A., & Hurst, J. R. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5120108 · Cited by 73
Self-citationDifferent dyspnoea perception in COPD patients with frequent and infrequent exacerbations
Scioscia, G., Blanco, I., Arismendi, E., Burgos, F., Gistau, C., Barbaro, M. P. F., Celli, B. R., O’Donnell, D. E., & Agustí, A. G. N. (2016) · Thorax · doi:10.1136/thoraxjnl-2016-208332 · Cited by 69
Self-citationVentilatory drive at rest and perception of exertional dyspnea in severe COPD.
Marin, J. M., de Oca, M. M., Rassulo, J., & Celli, B. (1999) · Chest · doi:10.1378/chest.115.5.1293 · Cited by 66
Self-citationRubio, N., Parker, R. A., Drost, E., Pinnock, H., Weir, C. J., Hanley, J., Mantoani, L. C., MacNee, W., McKinstry, B., & Rabinovich, R. (2017) · International Journal of COPD · doi:10.2147/copd.s120706 · Cited by 65
Treatable Traits That Predict Health Status and Treatment Response in Airway Disease
Hiles, S. A., Gibson, P. G., Agustí, A. G. N., & McDonald, V. M. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.09.046 · Cited by 65
Effing, T., Kerstjens, H. A. M., Monninkhof, E. M., van der Valk, P. D. L. P. M., Wouters, E. F. �., Postma, D. S., Zielhuis, G. A., & van der Palen, J. A. M. (2009) · CHEST Journal · doi:10.1378/chest.08-1680 · Cited by 55
Mahler, D., Waterman, L. A., Ward, J., McCusker, C., ZuWallack, R., & Baird, J. (2007) · Chest · doi:10.1378/chest.07-0703 · Cited by 54
Ekström, M. P., Johnson, M. J., Huang, C., & Currow, D. C. (2020) · European Respiratory Journal · doi:10.1183/13993003.02202-2019 · Cited by 50
Multi-level differential network analysis of COPD exacerbations
Noell, G. G., Cosío, B. G., Faner, R., Monsó, E., Peces‐Barba, G., de Diego, A., Esteban, C., Gea, J., Rodriguez‐Roisin, R., García-Núñez, M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00075-2017 · Cited by 49
Self-citationMinimal Clinically Important Difference—Exacerbations of COPD
Calverley, P. M. A. (2005) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-200050647 · Cited by 48
for the WARD-Project Group, Elvekjær, M., Aasvang, E. K., Olsen, R. M., Sørensen, H. B. D., Porsbjerg, C. M., Jensen, J. S., Haahr-Raunkjær, C., & Meyhoff, C. S. (2019) · Journal of Clinical Monitoring and Computing · doi:10.1007/s10877-019-00415-8 · Cited by 42
Gallego, M., Pomares, X., Capilla, S., Marcos, M. Á., Suarez, D. L., Monsó, E., & Montón, C. (2016) · International Journal of COPD · doi:10.2147/copd.s117129 · Cited by 35
Núñez, A., Marras, V., Harlander, M., Mekov, E., Esquinas, C., Turel, M., Lestan, D., Petkov, R. E., Yanev, N. A., Pirina, P., et al. (2020) · International Journal of COPD · doi:10.2147/copd.s240720 · Cited by 34
Rajeh, A. M. A., Aldabayan, Y. S., Aldhahir, A. M., Pickett, E., Quaderi, S. A., Alqahtani, J. S., Mandal, S., Lipman, M. C. I., & Hurst, J. R. (2020) · JMIR mhealth and uhealth · doi:10.2196/17597 · Cited by 30
Self-citationPneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease
Crisafulli, E., Manco, A. A., Ferrer, M., Huerta, A. H., Micheletto, C., Girelli, D., Clini, E. M., & Torres, A. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1702196 · Cited by 26
Self-citationNonpulmonary Influences on Gas Exchange
Rodriguez‐Roisin, R. (2014) · Comprehensive physiology · doi:10.1002/cphy.c100001 · Cited by 12
Self-citation
Cited by
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Agustí, A., Celli, B. R., Criner, G. J., Halpin, D., Anzueto, A., Barnes, P., Bourbeau, J., Han, M. K., Martinez, F. J., Montes de Oca, M., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00239-2023 · Cited by 1,303
Self-citationGlobal Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Agustí, A., Celli, B. R., Criner, G. J., Halpin, D., Anzueto, A., Barnes, P., Bourbeau, J., Han, M. K., Martinez, F. J., Montes de Oca, M., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202301-0106pp · Cited by 827
Self-citationTowards the elimination of chronic obstructive pulmonary disease: a Lancet Commission
Stolz, D., Mkorombindo, T., Schumann, D. M., Agusti, A., Ash, S. Y., Bafadhel, M., Bai, C., Chalmers, J. D., Criner, G. J., Dharmage, S. C., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01273-9 · Cited by 681
Self-citationGong, Y., Xu, C., Mo, C., Wu, J., Lin, H., Su, H., Zhang, Q., Zhang, Q., & Yang, S. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-02086-z · Cited by 6
Prevalence and Clinical Outcomes of Eosinophilic COPD in a Saudi Population: A Retrospective Study
Alshehri, F., Alghamdi, M., Aloqabi, F. A., Ibrahim, A., Tayeb, N., Hassosah, M., Abu-Zaid, A., Fan, H., & Vali, Y. (2025) · Saudi Journal of Medicine & Medical Sciences · doi:10.4103/sjmms.sjmms_248_24 · Cited by 3
Metadata
- Authors
- Celli, B. R., Fabbri, L. M., Aaron, S. D., Agusti, A., Brook, R., Criner, G. J., Franssen, F. M. E., Humbert, M., Hurst, J. R., O’Donnell, D., Pantoni, L., Papi, A., Rodriguez-Roisin, R., Sethi, S., Torres, A., Vogelmeier, C. F., & Wedzicha, J. A.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-12-01
- Volume
- 204
- Issue
- 11
- Pages
- 1251-1258
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W3203655695
- Cited by
- 371
- References
- 61
- FWCI
- 28.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.